Cytosorbents (CTSO) Misses Q3 EPS by 15c

Cytosorbents (NASDAQ: CTSO) reported Q3 EPS of ($0.25), $0.15 worse than the analyst estimate of ($0.10). Revenue for the quarter came in at $1.3 million versus the consensus estimate of $1.26 million.

For earnings history and earnings-related data on Cytosorbents (CTSO) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Motorsport Games Inc. (MSGM) Tops Q2 EPS by 33c
• UBS: 'We Believe Dollar Tree (DLTR) is Turning From a Transformation to a Growth Story'